Clinical trial

Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement

NCT00354939

Study summary

ClinicalTrials.gov

Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Insulin glargine Normalized identity: insulin glargine View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-10-01

PhasePHASE4

Conditions

Diabetes Mellitus Type 2unresolved

Interventions

Insulin glargineDRUG · verified · RxNorm: insulin glargine

Sponsors & collaborators

Sanofilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00354939 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.